Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4228 |
---|---|
High | 0.425 |
Low | 0.3954 |
Bid | 0.40 |
Offer | 0.43 |
Previous close | 0.41 |
Average volume | 896.95k |
---|---|
Shares outstanding | 40.13m |
Free float | 39.91m |
P/E (TTM) | -- |
Market cap | 16.05m USD |
EPS (TTM) | -0.9317 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Announcements
- Cognition Therapeutics Reports Financial Results for the Second Quarter 2024 and Provides Business and Clinical Update
- Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
- Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
- Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
- Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
- Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
- Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock
- Cognition Therapeutics Announces Proposed Public Offering of Common Stock
- Cognition Therapeutics to Present at the TD Cowen Health Care Conference
- Cognition Therapeutics CEO Issues Letter to Shareholders
More ▼